123 related articles for article (PubMed ID: 11161250)
1. Filtration of methylene blue-photooxidized plasma: influence on coagulation and cellular contamination.
Riggert J; Humpe A; Legler TJ; Wolf C; Simson G; Köhler M
Transfusion; 2001 Jan; 41(1):82-6. PubMed ID: 11161250
[TBL] [Abstract][Full Text] [Related]
2. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma.
Zeiler T; Riess H; Wittmann G; Hintz G; Zimmermann R; Müller C; Heuft HG; Huhn D
Transfusion; 1994 Aug; 34(8):685-9. PubMed ID: 8073485
[TBL] [Abstract][Full Text] [Related]
3. The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh-frozen plasma.
Garwood M; Cardigan RA; Drummond O; Hornsey VS; Turner CP; Young D; Williamson LM; Prowse CV
Transfusion; 2003 Sep; 43(9):1238-47. PubMed ID: 12919426
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of plasma after methylene blue and white light treatment in four Chinese blood centers.
Chunhui Y; Guohui B; Hong Y; Xiaopu X; Zherong B; Mingyuan W; Xinsheng Z; Juanjuan W; Changqing L; Wuping L
Transfus Apher Sci; 2013 Dec; 49(3):631-9. PubMed ID: 23928128
[TBL] [Abstract][Full Text] [Related]
5. Removal of methylene blue from plasma via an adsorbent filter.
AuBuchon JP; Pickard C; Herschel L; O'Connor JL; Lee E
Vox Sang; 1998; 74(1):1-6. PubMed ID: 9481852
[TBL] [Abstract][Full Text] [Related]
6. [The effect of methylene blue/photochemical method for virus inactivation on plasma components].
Zhou XP; Xu JB; Sun P; Yan F; Wang QL; Bu FR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):305-7. PubMed ID: 12844419
[TBL] [Abstract][Full Text] [Related]
7. [Effects of the adsorbent CAA for hemopurification on normal components of human plasma in removing methylene blue].
Ma Y; Xia Y; Yang X; Yu M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):311-3. PubMed ID: 12856607
[TBL] [Abstract][Full Text] [Related]
8. Elimination of both cell-free and cell-associated HIV infectivity in plasma by a filtration/methylene blue photoinactivation system.
Abe H; Yamada-Ohnishi Y; Hirayama J; Owada T; Ikeda H; Ikebuchi K
Transfusion; 2000 Sep; 40(9):1081-7. PubMed ID: 10988311
[TBL] [Abstract][Full Text] [Related]
9. Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants.
Aznar JA; Bonanad S; Montoro JM; Hurtado C; Cid AR; Soler MA; De Miguel A
Vox Sang; 2000; 79(3):156-60. PubMed ID: 11111234
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation, ProC(®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivation.
Thiele T; Hron G; Kellner S; Wasner C; Westphal A; Warkentin TE; Greinacher A; Selleng K
Blood Transfus; 2016 Jan; 14(1):66-72. PubMed ID: 26192785
[TBL] [Abstract][Full Text] [Related]
11. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
[TBL] [Abstract][Full Text] [Related]
12. Plasma temperature during methylene blue/light treatment influences virus inactivation capacity and product quality.
Gravemann U; Handke W; Sumian C; Alvarez I; Reichenberg S; Müller TH; Seltsam A
Vox Sang; 2018 May; 113(4):368-377. PubMed ID: 29484670
[TBL] [Abstract][Full Text] [Related]
13. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
Cardigan R; Philpot K; Cookson P; Luddington R
Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
[TBL] [Abstract][Full Text] [Related]
14. A potentially improved approach to methylene blue virus inactivation of plasma: the Maco Pharma Maco-Tronic system.
Hornsey VS; Drummond O; Young D; Docherty A; Prowse CV
Transfus Med; 2001 Feb; 11(1):31-6. PubMed ID: 11328569
[TBL] [Abstract][Full Text] [Related]
15. Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light.
Suontaka AM; Blombäck M; Chapman J
Transfusion; 2003 May; 43(5):568-75. PubMed ID: 12702176
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the hemostatic capacity of methylene blue-treated liquid (not frozen) plasma stored up 14 days at 2° to 6°C.
Rapaille A; Lotens A; de Valensart N; Najdovski T; Green L
Transfusion; 2021 Aug; 61(8):2450-2457. PubMed ID: 33913163
[TBL] [Abstract][Full Text] [Related]
17. Challenge study of the pathogen reduction capacity of the THERAFLEX MB-Plasma technology.
Reichenberg S; Gravemann U; Sumian C; Seltsam A
Vox Sang; 2015 Aug; 109(2):129-37. PubMed ID: 25899343
[TBL] [Abstract][Full Text] [Related]
18. The effect of leucocyte depletion on the quality of fresh-frozen plasma.
Cardigan R; Sutherland J; Garwood M; Krailadsiri P; Seghatchian J; Beard M; Beckman N; Williamson LM
Br J Haematol; 2001 Jul; 114(1):233-40. PubMed ID: 11472374
[TBL] [Abstract][Full Text] [Related]
19. Thrombin Generation Capacity of Methylene Blue-Treated Plasma Prepared by the Theraflex MB Plasma System.
Gravemann U; Kusch M; Koenig H; Mohr H; Mueller TH
Transfus Med Hemother; 2009; 36(2):122-127. PubMed ID: 20823993
[TBL] [Abstract][Full Text] [Related]
20. A biochemical comparison of a pharmaceutically licensed coagulation active plasma (Octaplas) with a universally applicable development product (Uniplas) and single-donor FFPs subjected to methylene-blue dye and white-light treatment.
Heger A; Römisch J; Svae TE
Transfus Apher Sci; 2006 Dec; 35(3):223-33. PubMed ID: 17118709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
